XENE Q2 2022 Earnings — Xenon Pharmaceuticals Inc. Revenue & Financial Results | Market Cap Arena

XENEXenon Pharmaceuticals Inc.

$5B

Q2 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$536,000-75.8% YoY

Gross Profit

-$22M-4031.7% margin

Operating Income

-$30M-5655.8% margin

Net Income

-$31M-5813.1% margin

EPS (Diluted)

$-0.55

QoQ Revenue Growth

-93.9%

Cash Flow

Operating Cash Flow

-$17M

Free Cash Flow

-$17M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$807M

Total Liabilities

$22M

Stockholders' Equity

$786M

Cash & Equivalents

$370M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$536,000	$2M	-75.8%
Gross Profit	-$22M	-$16M	-33.7%
Operating Income	-$30M	-$22M	-34.7%
Net Income	-$31M	-$22M	-40.9%

Revenue Segments

License And Service

$536,000100%